Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus
Open Access
- 1 August 2004
- journal article
- other
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 63 (8) , 961-968
- https://doi.org/10.1136/ard.2003.014274
Abstract
Background: In rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), patients demonstrate low levels of adrenal hormones. Objective: To investigate whether increased renal clearance and daily excretion contribute to this phenomenon. Methods: Thirty patients with RA, 32 with SLE, and 54 healthy subjects (HS) participated. Serum and urinary levels of cortisol, cortisone, 17-hydroxyprogesterone (17OHP), androstenedione, dehydroepiandrosterone (DHEA), and DHEA sulphate (DHEAS) were measured. Results: Clearance of DHEAS and DHEA was lower in patients than in HS, and clearance of androstenedione was somewhat higher in patients than in HS, but daily excretion of this latter hormone was low. Clearance of cortisol, cortisone, and 17OHP was similar between the groups. The total molar amount per hour of excreted DHEA, DHEAS, and androstenedione was lower in patients than HS (but similar for cortisol). Serum DHEAS levels correlated with urinary DHEAS levels in HS and patients, whereby HS excreted 5–10 times more of this hormone than excreted by patients. Low serum levels of adrenal androgens and cortisol in patients as compared with HS were confirmed, and proteinuria was not associated with changes of measured renal parameters. Conclusions: This study in patients with RA and SLE demonstrates that low serum levels of adrenal androgens and cortisol are not due to increased renal clearance and daily loss of these hormones. Decreased adrenal production or increased conversion or conjugation to downstream hormones are the most likely causes of inadequately low serum levels of adrenal hormones in RA and SLE.Keywords
This publication has 42 references indexed in Scilit:
- Cortisol elimination from plasma in premenopausal women with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2003
- Long‐term anti–tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretionArthritis & Rheumatism, 2003
- Adrenocorticotropin, Glucocorticoid, and Androgen Secretion in Patients with New Onset Synovitis/Rheumatoid Arthritis: Relations with Indices of InflammationJournal of Clinical Endocrinology & Metabolism, 2000
- Hypothalamo-pituitary-adrenal Axis and Growth Hormone Axis in Patients with Rheumatoid ArthritisScandinavian Journal of Rheumatology, 1999
- Abnormal hypothalamic—pituitary—adrenal axis function in rheumatoid arthritis. Effects of nonsteroidal antiinflammatory drugs and water immersionArthritis & Rheumatism, 1994
- Impairment of Adrenocortical Function Associated with Increased Plasma Tumor Necrosis Factor-Alpha and Interleukin-6 Concentrations in African TrypanosomiasisNeuroimmunomodulation, 1994
- Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritisArthritis & Rheumatism, 1988
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Admission criteria for immunogerontological studies in man: The senieur protocolMechanisms of Ageing and Development, 1984
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982